EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pushing the Boundaries of Liver Resection in Non-Colorectal Non-Neuroendocrine Metastatic Disease

Mario Serradilla Martín, José M. Ramia

Kosova Journal of Surgery · 15.08.2026 · 10 (2) · 88-98

DOI: 10.59928/zcxqax62 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kosova Journal of Surgery, online erschienen am 15.08.2026. Verfasst von Mario Serradilla Martín und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The liver, after the lymph nodes, is the most common site of metastatic disease. Liver resection is well established for colorectal and neuroendocrine liver metastases, but its role in metastases from other, non-colorectal non-neuroendocrine primary tumors remains debated because of the rarity of cases, the heterogeneity of the primary tumors involved, and the scarcity of prospective trials.

Objective

To synthesize the available evidence on outcomes after liver resection for non-colorectal non-neuroendocrine liver metastases according to the primary tumor of origin, and to identify the clinical and technical factors most consistently associated with improved survival.

Findings

A narrative review of clinical series, systematic reviews, and meta-analyses indexed in PubMed/ MEDLINE was performed, organized by primary tumor of origin. A recent systematic review and meta-analysis of 40 studies and 5,696 patients reported 3- and 5-year overall survival of 40% and 32%, respectively, after resection, with postoperative morbidity of 28% and 30day mortality of 2%. Outcomes varied markedly by tumor of origin: 5-year overall survival exceeded 40% for breast cancer, gastrointestinal stromal tumor, and melanoma, but remained below 25% for gastric and pancreatic cancer. Across nearly all tumor types, negative resection margins, limited hepatic disease, a disease-free interval longer than 12 months, and a favorable response to systemic therapy were the factors most consistently associated with better survival. Conclusions and Relevance: In carefully selected patients with limited hepatic disease, a favorable response to systemic therapy, and no uncontrolled extrahepatic disease, liver resection provides a clear survival benefit over non-surgical treatment and, in some subgroups, particularly breast cancer, gastrointestinal stromal tumor, and uveal melanoma, the possibility of long-term disease control. Because prospectively validated selection criteria are still lacking, the surgical decision should be individualized within a multidisciplinary team.

Zitieren

APA

Martín, M. S., & Ramia, J. M. (2026). Pushing the Boundaries of Liver Resection in Non-Colorectal Non-Neuroendocrine Metastatic Disease. Kosova Journal of Surgery, 10(2), 88-98. https://doi.org/10.59928/zcxqax62

Vancouver

Martín MS, Ramia JM. Pushing the Boundaries of Liver Resection in Non-Colorectal Non-Neuroendocrine Metastatic Disease. Kosova Journal of Surgery. 2026;10(2):88-98. doi:10.59928/zcxqax62

BibTeX
@article{Martn2026,
  author = {Martín, Mario Serradilla and Ramia, José M.},
  title = {Pushing the Boundaries of Liver Resection in Non-Colorectal Non-Neuroendocrine Metastatic Disease},
  journal = {Kosova Journal of Surgery},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {88--98},
  doi = {10.59928/zcxqax62}
}
Kostenlos starten →